Table 1.
Biomarkers of Potential Harm
| BOPH | Domain | Matrix |
|---|---|---|
| WBC count | Inflammation | Blood |
| HDL-cholesterol | Lipid metabolism | Serum |
| LDL-cholesterol | Lipid metabolism | Serum |
| TG | Lipid metabolism | Serum |
| TC | Lipid metabolism | Serum |
| Apo A1 | Lipid metabolism | Serum |
| Apo B | Lipid metabolism | Serum |
| s-ICAM-1 | Endothelial dysfunction | Serum |
| 8-epi-PGF2α | Oxidative stress | Urine |
| 11-DTX-B2 | Platelet activation | Urine |
| Glucose | Metabolic syndrome | Serum |
| HbA1C | Metabolic syndrome | Serum |
| Weight | Metabolic syndrome | — |
| Waist circumference | Metabolic syndrome | — |
| Fibrinogen | Cardiovascular risk factor | Plasma |
| Homocysteine | Cardiovascular risk factor | Serum |
| hs-CRP | Cardiovascular risk factor | Serum |
| Blood pressure | Cardiovascular risk factor | — |
| FEV1 | Lung function | — |
8-epi-PGF2α = 8-epi-prostaglandin F2α; 11-DTX-B2 = 11-dehydro-thromboxane B2; Apo A1 = apolipoprotein A1; Apo B = apolipoprotein B; BOPH = biomarker of potential harm; FEV1 = forced expiratory volume in 1 second; HbA1C = hemoglobin A1C; HDL = high-density lipoprotein; hs-CRP = high-sensitivity C-reactive protein; LDL = low-density lipoprotein; s-ICAM-1= soluble intercellular adhesion molecule-1; TC = total cholesterol; TG = triglycerides; WBC = white blood cells.